Paul K.S. Chan
The Chinese University of Hong Kong
669 Papers
4.3K Citations
Paul K.S. Chan is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 87, co-authored 602 publications. Previous affiliations of Paul K.S. Chan include Queen Mary University of London & University of Louisville.
Chat about Author
Papers
Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome
Michael H.M. Chan,Vincent Wai-Sun Wong,C. K. Wong,Paul K.S. Chan,C. M. Chu,David S.C. Hui,Michael W M Suen,Joseph J.Y. Sung,Sydney S.C. Chung,C. W. K. Lam +9 more
TL;DR: Blood leucocytes and lymphocyte subsets were reported to decrease, respectively, in 47% and up to 100% of 38 patients in Beijing, however, their prognostic implications have not been thoroughly investigated.
Laboratory and clinical aspects of human papillomavirus testing
TL;DR: Human papillomavirus (HPV) infection is associated with a wide spectrum of disease that ranges from self-limited skin warts to life-threatening cancers, and the role of HPV testing is expected to increase.
Estimates of Rotavirus Disease Burden in Hong Kong: Hospital-Based Surveillance
E. Anthony S. Nelson,John S. Tam,Joseph S. Bresee,Kin Hung Poon,Chi Hang Ng,Kin Sing Ip,T. Christopher Mast,Paul K.S. Chan,Umesh D. Parashar,Tai Fai Fok,Roger I. Glass +10 more
TL;DR: Combined active and passive surveillance data indicate that 4.6% of all general pediatric admissions to HA hospitals in Hong Kong were associated with rotavirus infection.
A double-blind placebo-controlled study of the effectiveness and tolerability of oral stevioside in human hypertension.
TL;DR: This study shows that oral stevioside is a well tolerated and effective modality that may be considered as an alternative or supplementary therapy for patients with hypertension.